Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression

Triple-negative breast cancer (TNBC) is often treated with anthracyclines (e.g., epirubicin or doxorubicin), but very little is known about anthracycline resistance, especially epirubicin resistance in TNBC. To identify novel long noncoding RNAs (lncRNAs) involved in epirubicin resistance in TNBC, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Fengliang, Yang, Sujin, Lv, Mingming, Chen, Fei, Yin, Hong, Gao, Sheng, Tang, Jinhai, Yu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970185/
https://www.ncbi.nlm.nih.gov/pubmed/33747911
http://dx.doi.org/10.3389/fonc.2021.592215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7970185/
https://www.ncbi.nlm.nih.gov/pubmed/33747911
http://dx.doi.org/10.3389/fonc.2021.592215

Ejemplares similares